PROCEPT BioRobotics Corp (PRCT) research

PROCEPT BioRobotics Corp
ShareXLinkedInReddit
Sector
Health Care
Last price
$19.44
As of

PROCEPT BioRobotics Corp (PRCT): 3 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-05.

As of . Source: SEC EDGAR filings for PRCT. Method and limitations.

SHARE THIS CARD

Share the PRCT intelligence card

A branded snapshot of PRCT: the smart money composite, cross family confluence, and the top current signal, with a link back to this page. Post it, download it, or embed it anywhere.

Kresmion PRCT intelligence card preview
Post to X
LIVE TERMINAL

See PRCT live in the terminal

Track PRCT's insider trades, 13F flows, options positioning, and cross asset confluence as they update, on one live board. Free account.

Open the live PRCT terminal, free

Active signals for PRCT

FREE, NO ACCOUNT

Every signal on PRCT, as it fires

You are seeing 5 of 22 signals recorded on PRCT since 2026-05-17.

The five above landed across 2 days. The other 17 were recorded on 3 other days. 18 of the 22 are institutional flow rows, which arrive in batches on filing days.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram
Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in PRCT (2026Q2)

Manager / securityMarket value% portfolioQoQ
MILLENNIUM MANAGEMENT LLCCUSIP 74276L105 · 2026Q2$14.1M0.01%,
TWO SIGMA INVESTMENTS, LPCUSIP 74276L105 · 2026Q2$1.2M0.00%,
CITADEL ADVISORS LLCCUSIP 74276L105 · 2026Q2$285K0.00%,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, PRCT

PRCT against its peers

PRCT's operating margin of -33.7% ranks in the 6th percentile of 25 Health Care sub-industry peers, fiscal periods ending between 2025-10-03 and 2026-05-31.

MetricPRCTPeer medianPercentilen
Revenue FY308M USD764M USD2525
Gross margin63.7%54.6%5616
Operating margin-33.7%0.4%625
Net margin-31.0%-2.2%625
Return on equity-26.1%-4.7%1725
P / En/a47.2xn/a9

Peers (25): IRMD, CSTL, GDRX, TDOC, STAA, TNDM, USPH, CERT, OMDA, AMN, BVS, CNMD, PNTG, TALK, HSTM, OMCL, VREX, ATEC, AHCO, EHAB, LMAT, ANGO, NVCR, XRAY, FLGT. Fiscal periods ending between 2025-10-03 and 2026-05-31. Every figure is one full fiscal year read from one annual filing (PRCT: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more PRCT signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to PRCTand get the insider, 13F, options, and confluence read in one view.

Open the live PRCT terminal, free